Open AccessP160 SERUM ALBUMIN WEEK 6/WEEK 0 RATIO AFTER ANTI-TNF BEST PREDICTS BOTH SHORT- AND LONG-TERM CLINICAL OUTCOMES IN ANTI-TNF-NAïVE ULCERATIVE COLITIS PATIENTS
Author(s) -
Sun-Ho Lee,
Kiju Chang,
Eun Mi Song,
Sung Wook Hwang,
Sang Hyoung Park,
DongHoon Yang,
JeongSik Byeon,
SeungJae Myung,
SukKyun Yang,
Byong Duk Ye
Publication year - 2018
Publication title -
inflammatory bowel diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.932
H-Index - 146
eISSN - 1536-4844
pISSN - 1078-0998
DOI - 10.1093/ibd/izy037.032
Subject(s) - medicine , infliximab , adalimumab , ulcerative colitis , hazard ratio , gastroenterology , confidence interval , discontinuation , proportional hazards model , log rank test , logistic regression , colectomy , surgery , rheumatoid arthritis , tumor necrosis factor alpha , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom